MPD: Project measures / variables set: Xenakis1 latency

Project measures / variables set: Xenakis1 latency_Rx

ID, description, units	MPD:111156 latency_Rx latency to move all four paws (extrapyramidal symptoms), treatment group [s] haloperidol study
Measures	• pre-treatment • post-treatment
Data set, strains	Xenakis1 CC RIX 73 strains sex: both age: 7-9wks
Procedure	inclined screen test
Comparison	control group vs. treated group
Ontology mappings	VT:0001392 locomotor behavior trait VT:0001516 motor coordination/balance trait VT:0002121 metabolism trait VT:0003492 involuntary movement trait VT:0010487 response to xenobiotic stimulus trait MP:0001392 abnormal locomotor behavior MP:0001516 abnormal motor coordination/balance MP:0003492 abnormal involuntary movement MP:0012693 abnormal haloperidol metabolism

Values Means Δ Means Z-scores

Graph Type Points Bars

Dimensions Width: × Height: px

Plot Options Hide Error Bars Strains on X-axis

Data Type:

Dimensions Height: px

Toggle Series

Plot Options Show Standard Error Show Point Labels Flip Axes Shared Tooltip Connect Gaps

Xenakis1 - latency to move all four paws (extrapyramidal symptoms), treatment group

Project	ID		Treatment	Measure / Variable Description	Panel	Strains tested	Sex	Age
Xenakis1	111156	inclined screen test	haloperidol	latency to move all four paws (extrapyramidal symptoms), treatment group [s] pre-treatment latency_Rx_pre	CC RIX	72	both	7-9wks
Xenakis1	111157	inclined screen test	haloperidol	latency to move all four paws (extrapyramidal symptoms), treatment group [s] post-treatment latency_Rx_post	CC RIX	70	both	7-9wks